Keeping it simple: genetics referrals for all invasive serous ovarian cancers (Q46601235)

23 December 2017

title

Keeping it simple: genetics referrals for all invasive serous ovarian cancers (English)

1 reference

23 December 2017

1 reference

R Demsky

1

1 reference

23 December 2017

J McCuaig

2

1 reference

23 December 2017

M Maganti

3

1 reference

23 December 2017

K J Murphy

4

1 reference

23 December 2017

B Rosen

5

1 reference

23 December 2017

S R Armel

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

22 May 2013

1 reference

23 December 2017

published in

Gynecologic Oncology

1 reference

23 December 2017

volume

130

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

329-333

1 reference

23 December 2017

The genetic attributable risk of breast and ovarian cancer

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Preventing future cancers by testing women with ovarian cancer for BRCA mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Meta-analysis of BRCA1 and BRCA2 penetrance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Family history and women with ovarian cancer: is it asked and does it matter?: An observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

What women with ovarian cancer think and know about genetic testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.05.003

10.1016/J.YGYNO.2013.05.003

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017